Dr Eric Watsky

Eric joined Rallybio in August 2018.  He has more than 20 years of experience in pharmaceutical research and development, as well as additional experience in patient care and clinical research.

Prior to joining Rallybio, Eric served as Vice President, Global Development Team Leader for Alexion Pharmaceuticals, where he led clinical programs for first-in-class therapies for multiple orphan and ultra-orphan diseases.  Previously, he held positions of increasing responsibility at Pfizer, rising to the role of Executive Director in the Specialty Care Business Unit focused on rare disease indications.  His work at Pfizer included both exploratory and late-stage clinical development of more than 30 approved drugs and drug candidates in support of both clinical research and commercialization.  Prior to Pfizer, Eric was a Senior Staff Research Fellow at the National Institute of Mental Health.

Eric received his MD from Boston University and has taught at the medical schools of Harvard, where he was Chief Resident in Psychopharmacology, and George Washington University.